Cargando…

Medullary Thyroid Cancer in Patients Older than 45—Epidemiologic Trends and Predictors of Survival

SIMPLE SUMMARY: Sporadic medullary thyroid cancer can occur anytime in life although they tend to present at a later age (≥45 years old) when the tumors are more easily discernible or become symptomatic. We present, in this study, a group of patients diagnosed with medullary thyroid cancer at or aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogna, Shekhar, Goldberg, Michael, Samson, David, Gachabayov, Mahir, Felsenreich, Daniel M., Azim, Asad, Dong, Xiang D (Eric)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692716/
https://www.ncbi.nlm.nih.gov/pubmed/33114488
http://dx.doi.org/10.3390/cancers12113124
_version_ 1783614577203740672
author Gogna, Shekhar
Goldberg, Michael
Samson, David
Gachabayov, Mahir
Felsenreich, Daniel M.
Azim, Asad
Dong, Xiang D (Eric)
author_facet Gogna, Shekhar
Goldberg, Michael
Samson, David
Gachabayov, Mahir
Felsenreich, Daniel M.
Azim, Asad
Dong, Xiang D (Eric)
author_sort Gogna, Shekhar
collection PubMed
description SIMPLE SUMMARY: Sporadic medullary thyroid cancer can occur anytime in life although they tend to present at a later age (≥45 years old) when the tumors are more easily discernible or become symptomatic. We present, in this study, a group of patients diagnosed with medullary thyroid cancer at or after 45 years of age when they are more likely to develop sporadic forms of medullary thyroid cancer with regard to their natural history and prognosis. In this study, we evaluated factors affecting survival in such patients. We found that the incidence of medullary thyroid cancer in patients ≥45 years of age is increasing. Our findings suggest that patients should be offered surgical resection at an early stage to improve their outcomes. ABSTRACT: Sporadic medullary thyroid cancer (MTC) can occur anytime in life although they tend to present at a later age (≥45 years old) when the tumors are more easily discernible or become symptomatic. We aimed to identify the factors affecting the survival in patients ≥45 years of age diagnosed with MTC. We analyzed the Surveillance, Epidemiology, and End Results (SEER) registry from 1973–2016 focusing on patients ≥45 years of age with MTC as an isolated primary. A total of 2533 patients aged ≥45 years with MTC were identified. There has been a statistically significant increase of 1.19% per year in the incidence of MTC for this group of patients. The disease was more common in females and the Caucasian population. Most patients had localized disease on presentation (47.6%). Increasing age and advanced stage of presentation were associated with worse survival with HR 1.05 (p < 0.001) and HR 3.68 (p < 0.001), respectively. Female sex and surgical resection were associated with improved survival with HR 0.74 (p < 0.001) and 0.36 (p < 0.001), respectively. In conclusion, the incidence of MTC in patients ≥45 years of age is increasing. Patients should be offered surgical resection at an early stage to improve their outcomes.
format Online
Article
Text
id pubmed-7692716
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76927162020-11-28 Medullary Thyroid Cancer in Patients Older than 45—Epidemiologic Trends and Predictors of Survival Gogna, Shekhar Goldberg, Michael Samson, David Gachabayov, Mahir Felsenreich, Daniel M. Azim, Asad Dong, Xiang D (Eric) Cancers (Basel) Article SIMPLE SUMMARY: Sporadic medullary thyroid cancer can occur anytime in life although they tend to present at a later age (≥45 years old) when the tumors are more easily discernible or become symptomatic. We present, in this study, a group of patients diagnosed with medullary thyroid cancer at or after 45 years of age when they are more likely to develop sporadic forms of medullary thyroid cancer with regard to their natural history and prognosis. In this study, we evaluated factors affecting survival in such patients. We found that the incidence of medullary thyroid cancer in patients ≥45 years of age is increasing. Our findings suggest that patients should be offered surgical resection at an early stage to improve their outcomes. ABSTRACT: Sporadic medullary thyroid cancer (MTC) can occur anytime in life although they tend to present at a later age (≥45 years old) when the tumors are more easily discernible or become symptomatic. We aimed to identify the factors affecting the survival in patients ≥45 years of age diagnosed with MTC. We analyzed the Surveillance, Epidemiology, and End Results (SEER) registry from 1973–2016 focusing on patients ≥45 years of age with MTC as an isolated primary. A total of 2533 patients aged ≥45 years with MTC were identified. There has been a statistically significant increase of 1.19% per year in the incidence of MTC for this group of patients. The disease was more common in females and the Caucasian population. Most patients had localized disease on presentation (47.6%). Increasing age and advanced stage of presentation were associated with worse survival with HR 1.05 (p < 0.001) and HR 3.68 (p < 0.001), respectively. Female sex and surgical resection were associated with improved survival with HR 0.74 (p < 0.001) and 0.36 (p < 0.001), respectively. In conclusion, the incidence of MTC in patients ≥45 years of age is increasing. Patients should be offered surgical resection at an early stage to improve their outcomes. MDPI 2020-10-26 /pmc/articles/PMC7692716/ /pubmed/33114488 http://dx.doi.org/10.3390/cancers12113124 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gogna, Shekhar
Goldberg, Michael
Samson, David
Gachabayov, Mahir
Felsenreich, Daniel M.
Azim, Asad
Dong, Xiang D (Eric)
Medullary Thyroid Cancer in Patients Older than 45—Epidemiologic Trends and Predictors of Survival
title Medullary Thyroid Cancer in Patients Older than 45—Epidemiologic Trends and Predictors of Survival
title_full Medullary Thyroid Cancer in Patients Older than 45—Epidemiologic Trends and Predictors of Survival
title_fullStr Medullary Thyroid Cancer in Patients Older than 45—Epidemiologic Trends and Predictors of Survival
title_full_unstemmed Medullary Thyroid Cancer in Patients Older than 45—Epidemiologic Trends and Predictors of Survival
title_short Medullary Thyroid Cancer in Patients Older than 45—Epidemiologic Trends and Predictors of Survival
title_sort medullary thyroid cancer in patients older than 45—epidemiologic trends and predictors of survival
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692716/
https://www.ncbi.nlm.nih.gov/pubmed/33114488
http://dx.doi.org/10.3390/cancers12113124
work_keys_str_mv AT gognashekhar medullarythyroidcancerinpatientsolderthan45epidemiologictrendsandpredictorsofsurvival
AT goldbergmichael medullarythyroidcancerinpatientsolderthan45epidemiologictrendsandpredictorsofsurvival
AT samsondavid medullarythyroidcancerinpatientsolderthan45epidemiologictrendsandpredictorsofsurvival
AT gachabayovmahir medullarythyroidcancerinpatientsolderthan45epidemiologictrendsandpredictorsofsurvival
AT felsenreichdanielm medullarythyroidcancerinpatientsolderthan45epidemiologictrendsandpredictorsofsurvival
AT azimasad medullarythyroidcancerinpatientsolderthan45epidemiologictrendsandpredictorsofsurvival
AT dongxiangderic medullarythyroidcancerinpatientsolderthan45epidemiologictrendsandpredictorsofsurvival